MORRIS PLAINS, N.J., Feb. 22, 2010 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Cynthia L. Sullivan, President and Chief Executive Officer, will be participating in the BMC Boston Healthcare one-on-one Conference at the Hilton Boston Financial District, Boston, Massachusetts, on March 1, 2010. This conference offers investors the opportunity to experience focused, customized, one-on-one meetings with senior management. There will be no formal presentation.
